Skip to search formSkip to main contentSkip to account menu

AM424

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

leukemia inhibitory factor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A Randomized, Double-blinded, Placebo-controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2004
2004
Scope Note 44 Vulnerability , Vulnerable Populations , and Policy
[ 411 ] Kennedy Institute of Ethics Journal Vol. 14, No. 4, 411–425 © 2004 by the National Reference Center for Bioethics… 
Review
2000
Review
2000
AM424: History Of A Novel Drug Candidate
1. Leukaemia inhibitory factor (LIF) is a 180 amino acid single‐chain protein, named after its effect on haematopoietic cells… 
Review
1998
Review
1998
LIF (AM424), a promising growth factor for the treatment of ALS
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)